[1]
S. Chauhan, H. Krishna, V. K. Dhanni, J. Kumar, and G. S. Raghuwanshi, “Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus ”, ajm, vol. 4, no. 2, pp. 50–54, Dec. 2022, Accessed: Nov. 20, 2026. Available: https://medjournal.co.in/index.php/ajm/article/view/82